The immunomodulatory effects of topiramate on azoxymethane-induced colon carcinogenesis in rats: The role of the inflammatory cascade, vascular endothelial growth factor, AKT/mTOR/MAP kinase signaling and the apoptotic markers.

International Immunopharmacology
Ahmed M KabelHany H Arab

Abstract

Colon cancer is a malignant condition that affects the lower gastrointestinal tract and has unfavorable prognosis. Its mechanisms range from enhanced production of reactive oxygen species, inflammatory changes in the colon microenvironment and affection of the apoptotic pathways. Due to the high incidence of resistance of colon cancer to the traditional chemotherapeutic agents, a need for finding safe/effective agents that can attenuate the malignant changes had emerged. To investigate the possible immunomodulatory and antitumor effects of topiramate on azoxymethane-induced colon cancer in rats. Fifty male Wistar rats were randomized into five equal groups as follows: Control; azoxymethane-induced colon cancer; azoxymethane + methyl cellulose; azoxymethane + topiramate small dose; and azoxymethane + topiramate large dose. The body weight gain, serum carcinoembryonic antigen (CEA), tissue antioxidant status, proinflammatory cytokines, vascular endothelial growth factor (VEGF), Nrf2/HO-1 content, p-AKT, mTOR, p38 MAP kinase, caspase 9, nerve growth factor beta and beclin-1 were measured. Also, parts of the colon had undergone histopathological and immunohistochemical evaluation. Topiramate improved the body weight gain, decreased...Continue Reading

References

Jan 1, 1978·Methods in Enzymology·J A Buege, S D Aust
Sep 20, 2007·Alcoholism, Clinical and Experimental Research·Garth A Hargreaves, Iain S McGregor
May 17, 2008·CNS Neuroscience & Therapeutics·Richard P Shank, Bruce E Maryanoff
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Marco MulaFrancesco Monaco
Jun 16, 2012·Virchows Archiv : an International Journal of Pathology·Emma WilliamsSuha Deen
Jul 3, 2013·Digestive Diseases and Sciences·Zhihong ChenJifang Wen
Apr 29, 2016·Headache·Scott D SpritzerJoseph F Drazkowski
Oct 1, 2016·World Journal of Gastroenterology : WJG·Pia ViikiläCaj Haglund
Jun 1, 2017·International Journal of Molecular Sciences·Kelsey E Murphy, Joshua J Park
Jun 24, 2017·Current Pharmacology Reports·Nicholas J W RattrayCaroline H Johnson
Aug 5, 2017·Journal of Cancer·Hao LiuYunlong Lei
Sep 21, 2017·Oncology Letters·Xiaolin YuRensheng Chen
May 12, 2019·Cancer Metastasis Reviews·Silvia Pastorekova, Robert J Gillies
Jun 21, 2019·Gastroenterology Report·Susan FotheringhamDavid J Kerr
Jul 13, 2019·Annals of Surgical Treatment and Research·André GoulartPedro Leão
Aug 9, 2019·Journal of Neuro-oncology·Mohammed AlbatanyRobert Bartha
Apr 23, 2020·International Journal of Molecular Sciences·Angelina PrantedaGianluca Bossi
May 12, 2020·World Journal of Gastroenterology : WJG·Apolonia NovilloAna Fernández-Santander
Sep 26, 2020·Cell Death & Disease·Rui LiuYuanyan Liu
Dec 31, 2020·Biomolecules·Carmine StolfiGiovanni Monteleone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

The American Journal of Psychiatry
Stefan P Kruszewski, Steven G Klotz
The Annals of Pharmacotherapy
K H LittrellC G Johnson
Revista de neurologia
C Maciá- BobesM Arias Rodríguez
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
A I Fedin, E Yu Solov'eva
© 2021 Meta ULC. All rights reserved